RECURSION PHARMACEUTICALS IN shareholders Q2 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.

RECURSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 14,300$106,8210.00%
Ameritas Investment Partners, Inc. 11,270$84,1870.00%
Activest Wealth Management 186$5,0240.00%
Nuveen Asset Management, LLC 1,125,645$8,408,5680.00%
Jump Financial, LLC 11,849$88,5120.00%
IEQ CAPITAL, LLC 17,920$133,8620.00%
BALDWIN BROTHERS LLC/MA 5,502$41,1000.00%
METROPOLITAN LIFE INSURANCE CO/NY 7,549$56,3910.00%
Ensign Peak Advisors, Inc 169,220$1,264,0730.00%
AMERICAN INTERNATIONAL GROUP, INC. 65,690$490,7040.00%
LAZARD ASSET MANAGEMENT LLC 345,123$2,5780.00%
FMR LLC 4,559,597$34,060,1880.00%
Squarepoint Ops LLC 123,974$926,0860.00%
RHUMBLINE ADVISERS 257,975$1,927,0730.00%
Skandinaviska Enskilda Banken AB (publ) 47,800$3580.00%
BlackRock Inc. 11,619,427$86,797,1180.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 158,392$1,183,1880.00%
New Millennium Group LLC 275$2,0540.00%
VANGUARD GROUP INC 11,259,832$84,110,9460.00%
Arizona State Retirement System 36,068$269,4280.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.